How Much Do GLP-1 Drugs Cost Without Insurance in 2026?

Without insurance, your monthly cost depends on which of three paths you take, not on luck at the pharmacy counter:

• Full brand-name list price is the most expensive route. According to the manufacturers' published list prices, the leading FDA-approved weight-management drugs — Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound (tirzepatide) — carry list prices above $1,000 per month. Cash payers almost never need to pay this, because both companies sell directly at a discount.
• Manufacturer cash programs are the mid tier. Eli Lilly sells Zepbound single-dose vials through its LillyDirect Self Pay channel, and Novo Nordisk sells Wegovy cash-pay through NovoCare. Both publish their own cash prices, which have come down meaningfully from list and which you should confirm directly because they are revised periodically.
• Compounded telehealth is typically the lowest monthly cost. Platforms prescribing compounded semaglutide or tirzepatide often advertise the cheapest numbers — but compounded drugs are not FDA-approved, and the legal landscape for compounding these molecules changed once the FDA declared the official shortages resolved.

One number people forget: the visit or membership fee. Your real monthly cost is the drug plus the cost of the consultation, any required labs, and shipping. Some platforms fold all of that into one price; others itemize it. Always compare all-in.

List price (also called wholesale acquisition cost) is the manufacturer's sticker price before any discount, rebate, or insurance adjustment. For GLP-1 weight-management drugs it sits above $1,000 per month per the manufacturers' own published figures. That headline number drives most of the sticker shock people feel — and most of the confusion, because very few cash payers actually transact at list.

The reason: both major manufacturers now run direct cash-pay channels specifically for people without coverage. The list price is the ceiling, not the floor. If you are paying out of pocket and someone quotes you full list, that is a signal to look at the manufacturer's own cash program first.

A note on what these drugs are: semaglutide (the molecule in Wegovy) is a GLP-1 receptor agonist, and tirzepatide (in Zepbound) is a dual GIP and GLP-1 receptor agonist. Both are FDA-approved for chronic weight management in adults who meet the labeled criteria, used alongside diet and physical activity. This guide is about cost and access, not about whether any medication is appropriate for you — that is a decision for you and a licensed clinician.

The two cash-pay programs run by the drugmakers themselves are the most straightforward way to get the genuine, FDA-approved brand drug without insurance.

Eli Lilly — LillyDirect (Zepbound)

Lilly sells Zepbound single-dose vials cash-pay through its LillyDirect Self Pay pharmacy channel. The vial format is priced below the auto-injector pen list price, and Lilly publishes the current self-pay amount on its own site. Because Lilly has adjusted this pricing more than once, treat any figure you see quoted elsewhere as a starting point and confirm the live price at LillyDirect before paying.

Novo Nordisk — NovoCare (Wegovy)

Novo Nordisk sells Wegovy cash-pay through NovoCare. As with Lilly, Novo publishes the current cash price directly, and it has been revised over time. Verify the current Wegovy cash price at NovoCare's own pharmacy before purchasing.

Both programs still require a valid prescription from a licensed clinician. The cash program changes where and how you buy the drug and at what price — it does not remove the requirement to be evaluated and prescribed by a provider.

Compounded GLP-1 medications — typically compounded semaglutide or tirzepatide prepared by a compounding pharmacy and prescribed through a telehealth platform — usually carry the lowest advertised monthly prices. That is the appeal. The caveats are just as important as the price.

Compounded drugs are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality the way it reviews brand-name drugs. Compounding is a legitimate, regulated pharmacy practice, but a compounded version of a drug is not the same regulatory product as the approved brand.

The legal context changed. During the official shortages of semaglutide and tirzepatide, compounders were able to produce these molecules more broadly. After the FDA declared those shortages resolved, the conditions under which these specific molecules may be compounded narrowed considerably. Any platform's compounded GLP-1 offering should be evaluated in that current context, and availability may differ from what was advertised even a few months earlier.

A prescription and consult are still required. Legitimate compounded GLP-1s are prescription medications obtained after an evaluation by a licensed provider. If a source offers to ship you a GLP-1 without any consultation, that is a serious red flag — not a shortcut. Steer clear of "research chemical," "not for human consumption," or grey-market sources entirely; those are not legitimate pharmacies and fall outside any of the three paths in this guide.

Many telehealth platforms package the medical visit, ongoing clinician support, and medication into a subscription. What's included — and whether the price you see is the drug, the membership, or both — varies a lot, so read each provider's terms and confirm current pricing on its own site. The platforms below are among those operating in the GLP-1 weight-management space; their inclusion here is editorial and is not a recommendation that any drug is right for you.

• ShedRx — telehealth weight-management platform offering GLP-1 programs. Visit ShedRx
• GobyMeds — telehealth metabolic-health and weight-management platform. Visit GobyMeds
• Measured Health — clinician-led weight-management telehealth. Visit Measured Health
• Elevate Health — GLP-1 weight-management telehealth program. Visit Elevate Health
• TrimRx — telehealth weight-management offerings. Visit TrimRx
• Brello Health — telehealth metabolic and weight-management care. Visit Brello Health
• DrHouse — telehealth platform with online medical consultations. Visit DrHouse
• NovoCare — Novo Nordisk's own cash-pay pharmacy for Wegovy. Visit NovoCare
• LillyDirect — Eli Lilly's own direct pharmacy and Self Pay channel for Zepbound. Visit LillyDirect

For comparison, several other consumer telehealth brands also market weight-management programs — including Ivim Health, Henry Meds, Eden, MEDVi, Ro, Hims & Hers, Mochi Health, Found, Noom Med, Calibrate, LifeMD, PlushCare, WeightWatchers Clinic, and Form Health. We mention these editorially for context; we don't earn anything from naming them, and listing a brand is not an endorsement of any specific medication.

To compare paths honestly, add up everything you'll actually pay in a month, not just the drug:

1. Medication cost — the per-month price of the drug at your chosen dose. With brand programs, confirm whether the price is per vial/pen or per month's supply.
2. Consultation or membership fee — some telehealth platforms bundle this into one price; others bill a separate visit or subscription fee. Brand cash programs still require a prescription from a provider, whose visit may have its own cost.
3. Labs and follow-ups — some programs include baseline labs and check-ins; others don't.
4. Shipping — frequently included, but confirm.
5. Dose changes — GLP-1 dosing is often titrated over time, which can change your monthly cost as the dose changes. Ask how price tracks with dose.

Run the all-in number for each path you're considering, then verify each component's current price at the source. The cheapest advertised drug isn't always the cheapest program once the visit and labs are included.

• Is this the FDA-approved brand drug or a compounded version? Compounded products are not FDA-approved; make sure you know which you're buying.
• Is a licensed provider evaluating me before prescribing? The answer should always be yes. No legitimate path ships prescription GLP-1s without a consultation.
• What exactly is included in the price? Drug only, or drug plus visit, labs, and shipping?
• What happens to my cost as the dose increases? Titration can change the monthly figure.
• What is the current price today? Pricing on every path in this guide changes; confirm at the source, not from a screenshot or an old article.
• For compounded products: what is the pharmacy, and how is quality handled? A legitimate program should be transparent about the compounding pharmacy it works with.

What we can state confidently: The three-tier structure (full list price, manufacturer cash programs, compounded telehealth) is real and stable. Manufacturer list prices for the leading weight-management GLP-1s exceed $1,000/month per the companies' published figures. Eli Lilly sells Zepbound single-dose vials cash-pay via LillyDirect, and Novo Nordisk sells Wegovy cash-pay via NovoCare. Compounded GLP-1s are not FDA-approved, and the compounding landscape tightened after the FDA resolved the semaglutide and tirzepatide shortages.

What we deliberately did not pin to a single dollar figure: the exact current cash price of any brand program or telehealth subscription. These numbers are revised frequently, and quoting a stale figure would mislead you more than help. We've pointed you to the source for each instead. Likewise, we did not assign specific monthly prices to individual telehealth platforms, because their bundled offerings and pricing differ and change; confirm each on its own site.

What we will not do: promise an outcome, quote efficacy numbers outside of what a manufacturer's FDA label or a published trial states, or imply you can get these medications without a prescription. None of those would be honest.